Literature DB >> 17079465

Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion.

Manabu Kurayoshi1, Naohide Oue, Hideki Yamamoto, Michiko Kishida, Atsuko Inoue, Toshimasa Asahara, Wataru Yasui, Akira Kikuchi.   

Abstract

Wnt-5a is a representative ligand that activates a beta-catenin-independent pathway in the Wnt signaling. Although abnormal activation of beta-catenin-dependent pathway is often observed in human cancer, the relationship between beta-catenin-independent pathway and tumorigenesis is not clear. We sought to clarify how Wnt-5a is involved in aggressiveness of gastric cancer. Abnormal expression of Wnt-5a was observed in 71 of 237 gastric cancer cases by means of immunohistochemistry. The positivity of Wnt-5a expression was correlated with advanced stages and poor prognosis of gastric cancer. Wnt-5a had the abilities to stimulate cell migration and invasion in gastric cancer cells. Wnt-5a activated focal adhesion kinase and small GTP-binding protein Rac, both of which are known to play a role in cell migration. Cell migration, membrane ruffling, and turnover of paxillin were suppressed in Wnt-5a knockdown cells. Furthermore, anti-Wnt-5a antibody suppressed gastric cancer cell migration. These results suggest that Wnt-5a stimulates cell migration by regulating focal adhesion complexes and that Wnt-5a is not only a prognostic factor but also a good therapeutic target for gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079465     DOI: 10.1158/0008-5472.CAN-06-2359

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  188 in total

1.  The Dishevelled-associating protein Daple controls the non-canonical Wnt/Rac pathway and cell motility.

Authors:  Maki Ishida-Takagishi; Atsushi Enomoto; Naoya Asai; Kaori Ushida; Takashi Watanabe; Takahiko Hashimoto; Takuya Kato; Liang Weng; Shinji Matsumoto; Masato Asai; Yoshiki Murakumo; Kozo Kaibuchi; Akira Kikuchi; Masahide Takahashi
Journal:  Nat Commun       Date:  2012-05-29       Impact factor: 14.919

Review 2.  The "O" class: crafting clinical care with FoxO transcription factors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

3.  Proteomics profiling of Madin-Darby canine kidney plasma membranes reveals Wnt-5a involvement during oncogenic H-Ras/TGF-beta-mediated epithelial-mesenchymal transition.

Authors:  Yuan-Shou Chen; Rommel A Mathias; Suresh Mathivanan; Eugene A Kapp; Robert L Moritz; Hong-Jian Zhu; Richard J Simpson
Journal:  Mol Cell Proteomics       Date:  2010-05-28       Impact factor: 5.911

4.  Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis.

Authors:  Mijung Kwon; Soo Jin Lee; Yarong Wang; Yevangelina Rybak; Alex Luna; Srilakshmi Reddy; Asha Adem; Brian T Beaty; John S Condeelis; Steven K Libutti
Journal:  Int J Cancer       Date:  2014-02-20       Impact factor: 7.396

5.  Wnt5A activates the calpain-mediated cleavage of filamin A.

Authors:  Michael P O'Connell; Jennifer L Fiori; Katherine M Baugher; Fred E Indig; Amanda D French; Tura C Camilli; Brittany P Frank; Rachel Earley; Keith S Hoek; Joanne H Hasskamp; E George Elias; Dennis D Taub; Michel Bernier; Ashani T Weeraratna
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

Review 6.  A Wnt survival guide: from flies to human disease.

Authors:  Andy J Chien; William H Conrad; Randall T Moon
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

7.  Beta-arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways.

Authors:  Vítĕzslav Bryja; Alexandra Schambony; Lukás Cajánek; Isabel Dominguez; Ernest Arenas; Gunnar Schulte
Journal:  EMBO Rep       Date:  2008-10-24       Impact factor: 8.807

8.  Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target.

Authors:  S Fujii; S Matsumoto; S Nojima; E Morii; A Kikuchi
Journal:  Oncogene       Date:  2014-12-08       Impact factor: 9.867

Review 9.  WNT signalling pathways as therapeutic targets in cancer.

Authors:  Jamie N Anastas; Randall T Moon
Journal:  Nat Rev Cancer       Date:  2013-01       Impact factor: 60.716

10.  A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.

Authors:  Veronika Jenei; Victoria Sherwood; Jillian Howlin; Rickard Linnskog; Annette Säfholm; Lena Axelsson; Tommy Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.